Suchergebnisse

Zeitschriftenartikel (11)

  1. 2017
    Lisboa, M. P.; Khan, N.; Martin, C.; Xu, F.-F.; Reppe, K.; Geissner, A.; Govindan, S.; Witzenrath, M.; Pereira, C. L.; Seeberger, P. H.: Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proceedings of the National Academy of Sciences of the United States of America 114 (42), S. 11063 - 11068 (2017)
  2. 2016
    Bröcker, F.; Martin, C. E.; Wegner, E.; Mattner, J.; Baek, J. Y.; Pereira, C. L.; Chakkumkal, A.; Seeberger, P. H.: Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections. Cell Chemical Biology 23 (8), S. 1014 - 1022 (2016)
  3. Broecker, F.; Hanske, J.; Martin, C. E.; Baek, J. Y.; Wahlbrink, A.; Wojcik, F.; Hartmann, L.; Rademacher, C.; Chakkumkal, A.; Seeberger, P. H.: Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nature Communications 7, 11224 (2016)
  4. Möginger, U.; Resemann, A.; Martin, C. E.; Parameswarappa, S.; Govindan, S.; Wamhoff, E.-C.; Broecker, F.; Suckau, D.; Pereira, C. L.; Chakkumkal, A. et al.; Seeberger, P. H.; Kolarich, D.: Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports 6, 20488 (2016)
  5. 2015
    Zacco, E.; Chakkumkal, A.; Martin, C. E.; von Berlepsch, H.; Brandenburg, E.; Seeberger, P. H.; Koksch, B.: A Self-Assembling Peptide Scaffold for the Multivalent Presentation of Antigens. Biomacromolecules 16 (7), S. 2188 - 2197 (2015)
  6. 2013
    Anish, C.; Martin, C. E.; Wahlbrink, A.; Bogdan, C.; Ntais, P.; Antoniou, M.; Seeberger, P. H.: Immunogenicity and Diagnostic Potential of Synthetic Antigenic Cell Surface Glycans of Leishmania. ACS CHEMICAL BIOLOGY 8 (11), S. 2412 - 2422 (2013)
  7. Martin, C. E.; Broecker, F.; Oberli, M. A.; Komor, J.; Mattner, J.; Anish, C.; Seeberger, P. H.: Immunological Evaluation of a Synthetic Clostridium difficile Oligosaccharide Conjugate Vaccine Candidate and Identification of a Minimal Epitope. Journal of the American Chemical Society 135 (26), S. 9713 - 9722 (2013)
  8. Martin, C. E.; Broecker, F.; Eller, S.; Oberli, M. A.; Anish, C.; Pereira, C. L.; Seeberger, P. H.: Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications 49 (64), S. 7159 - 7161 (2013)
  9. Yang, Y.; Oishi, S.; Martin, C. E.; Seeberger, P. H.: Diversity-oriented Synthesis of Inner Core Oligosaccharides of the Lipopolysaccharide of Pathogenic Gram-negative Bacteria. Journal of the American Chemical Society 135 (16), S. 6262 - 6271 (2013)
  10. 2012
    Yang, Y.; Martin, C. E.; Seeberger, P. H.: Total synthesis of the core tetrasaccharide of Neisseria meningitidis lipopolysaccharide, a potential vaccine candidate for meningococcal diseases. Chemical Science 3 (3), S. 896 - 899 (2012)
  11. 2011
    Martin, C. E.; Weishaupt, M. W.; Seeberger, P. H.: Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit. Chemical Communications 47 (37), S. 10260 - 10262 (2011)

Meeting Abstract (1)

  1. 2014
    Bröcker, F.; Martin, C.; Hanske, J.; Rademacher, C.; Pereira, C. L.; Anish, C.; Seeberger, P.: Deciphering Glycan-Antibody Interactions: towards a Carbohydrate-based Vaccine against Clostridium difficile. In: GLYCOBIOLOGY, Bd. 24, S. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, 16. November 2014 - 19. November 2014. (2014)

Hochschulschrift - Doktorarbeit (1)

  1. 2014
    Martin, C. E.: Chemical Synthesis and Biological Evaluation of Cell Surface Carbohydrate Antigens for Rational Vaccine Design. Dissertation, 188 S., Freie Universität Berlin, Berlin (2014)

Patent (3)

  1. 2016
    Chakkumkal, A.; Lisboa, M.; Martin, C. E.; Pereira, C. L.; Seeberger, P. H.; Khan, N.: Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
  2. Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
  3. 2013
    Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)
 
Zur Redakteursansicht
loading content